Union World Conference on Lung Health 2019

Congress Overview

The Union World Conference of Lung Health gathers global experts, opinion formers, and delegates from around the world working to end suffering caused by lung disease, with a focus on the challenges faced by low- and lower-middle income population. Roche is committed to eradicate tuberculosis globally as part of a comprehensive diagnostic access program. In 2019, the Global Access Program was expanded to include Tuberculosis (TB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV). Along with HIV, the Global Access Program enables a comprehensive diagnostic approach benefiting programs and patients.

Take aim at TB

Come visit the Roche booth (D6305) to find out more about the Global Access Program and its product portfolio.


Hyderabad International Convention Centre

Novotel & HICC Complex

Izzathnagar, Kondapur

Hyderabad, Telangana 500081


Exhibition Hours

  • Wednesday, 30 October: 14:00 – 21:00
  • Thursday, 31 October: 08:30 – 17:00
  • Friday, 1 November: 08:30 – 17:00
  • Saturday, 2 November: 08:30 – 18:00

Roche Satellite Session

Friday, 01 November, 7:30 am

Location: Hall 1

The Role of Centralized Testing; From Bedside to Impact


Despite advancements in diagnostics and treatment, tuberculosis remains the number one infectious disease cause of mortality with 36% of infected patients remaining undiagnosed or unreported. Comorbidities with HIV and hepatitis, and drug resistance further challenge the diagnostic progress. Tuberculosis is a multi-faceted problem that needs to be addressed with diagnostics strategies tailored for the setting.


We will welcome patient advocate Rhea Lobo to tell her story and moderate a discussion around access to tuberculosis diagnostics.

Rhea Lobo

Rhea Lobo

Satellite Session Chair

International Award-Winning Filmmaker, Health Journalist, TB Advocate and Writer


Dr. Katharina Kranzer


Associate Professor Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine

Michael Campbell

Michael Campbell

Senior Director, Tuberculosis Access Team at Clinton Health Access Initiative

Samuel Schumacher

Dr. Samuel Schumacher

PhD Epidemiology, MSc Molecular Biotechnology

Deputy Head of TB, FIND